Intrinsic vs Extrinsic Restrictive Lung Disease: Telling Them Apart
Both intrinsic and extrinsic restrictive lung diseases produce the same physiologic endpoint—reduced lung volumes because the lungs cannot fully expand. The pivotal distinction is WHERE the problem lies: intrinsic disease damages the lung parenchyma itself (fibrosis, inflammation), whereas extrinsic disease leaves the lungs normal and limits expansion from outside (chest wall, pleura, or respiratory muscles). DLCO (interpreted alongside alveolar volume) and HRCT are the anchors that arbitrate between them.
How to tell them apart
| Feature | Intrinsic Restrictive Lung Disease (Interstitial Lung Disease) | Extrinsic Restrictive Lung Disease |
|---|---|---|
| Lung parenchyma | Abnormal—fibrosis and/or inflammation of the alveolar walls (interstitium) | Normal—the lungs are intact; the problem is outside them |
| DLCO corrected for alveolar volume (DLCO/VA, or KCO) | Reduced KCO, reflecting genuine loss of functioning alveolar-capillary surface area | Normal or even increased KCO—the membrane is intact, and the crowded, well-perfused alveoli transfer gas efficiently for the volume available |
| Raw (uncorrected) DLCO | Reduced, driven by true parenchymal loss | May be normal or mildly reduced simply because alveolar volume (VA) is low—correcting for VA (KCO) reveals it is preserved |
| HRCT findings | Diffuse parenchymal abnormalities—infiltrates, fibrosis, honeycombing, ground-glass opacity | Normal lung parenchyma; may show chest wall or pleural abnormality |
| Lung exam | Fine, 'Velcro-like' crackles at the bases that do not clear with coughing | Clear lungs with no crackles |
| Example causes | IPF, sarcoidosis, connective tissue disease-associated ILD, pneumoconiosis, hypersensitivity pneumonitis | Obesity, kyphoscoliosis, neuromuscular disease, pleural disease |
| Associated exam clues | Clubbing (IPF, advanced fibrosis), CTD signs such as sclerodactyly or heliotrope rash, and sarcoidosis clues such as erythema nodosum | Structural or mechanical clues such as kyphoscoliotic chest deformity or morbid obesity with positional hypoxemia |
| Key diagnostic clue | Reduced KCO + abnormal HRCT + basilar crackles | Preserved KCO + normal lung parenchyma on CT |
The reasoning
Start by confirming true restriction with lung volumes (TLC)—do not rely on spirometry alone. Once restriction is established, the arbitrating question is whether the lungs themselves are diseased. Diffusing capacity is the pivot, but interpret it correctly: raw DLCO can be low in BOTH patterns because it depends on alveolar volume, which is reduced whenever the lungs are small. The discriminating value is DLCO corrected for alveolar volume (KCO). A reduced KCO means genuine loss of alveolar-capillary surface area and points toward intrinsic parenchymal disease, while a normal or increased KCO tells you the membrane is intact and the problem lies outside the lungs. HRCT is the confirmatory cornerstone—diffuse infiltrates, fibrosis, honeycombing, or ground-glass anchor an ILD diagnosis (and the specific pattern, e.g. UIP vs NSIP, guides further management), whereas normal parenchyma with a chest wall or pleural abnormality confirms extrinsic restriction. The bedside exam reinforces this: fine Velcro crackles and clubbing favor intrinsic ILD, while clear lungs in a patient with kyphoscoliosis, morbid obesity, or neuromuscular weakness favor extrinsic disease. The triad of reduced KCO + abnormal HRCT + basilar crackles is the fingerprint of ILD.
Key tests
- DLCO with alveolar-volume correction (KCO/DLCO-VA): raw DLCO can be reduced in either pattern because it scales with alveolar volume, but KCO is reduced in intrinsic ILD (true loss of alveolar-capillary surface) and normal-to-increased in extrinsic restriction (intact membrane in a small lung)—this correction is the single best physiologic discriminator.
- High-resolution CT (HRCT): shows diffuse parenchymal disease (honeycombing/UIP, ground-glass/NSIP, HP patterns) in intrinsic ILD; normal lung parenchyma with possible chest wall or pleural abnormality in extrinsic disease.
- Pulmonary function testing with lung volumes (TLC): confirms restriction (reduced TLC and FVC, preserved FEV1/FVC ratio) in both, so it establishes the restrictive pattern but must be combined with DLCO/KCO to localize the cause—spirometry alone can be misleading.
- Detailed history and physical exam: occupational/environmental/drug exposures and CTD symptoms with Velcro crackles and clubbing point to intrinsic ILD, whereas morbid obesity, spinal deformity, or neuromuscular weakness with clear lungs point to extrinsic restriction.
What they share
- Restrictive pattern on pulmonary function testing with reduced lung volumes (reduced TLC, reduced FVC, normal or elevated FEV1/FVC)
- Progressive dyspnea on exertion as the dominant presenting complaint
- Reduced overall chest expansion on inspection
- A modestly reduced raw DLCO can be seen in both, because DLCO scales with alveolar volume—so the raw value alone does not separate them
- The lungs cannot fully expand, so both give a physiologically similar picture of restriction despite completely different mechanisms and management
Pitfalls
- Being falsely reassured by 'clear lungs.' Extrinsic restriction (and vascular disease like PE) typically has a normal lung exam, so quiet breath sounds do not exclude significant pathology—listen to the vital signs and oxygenation.
- Relying on spirometry alone to diagnose restriction. Confirm with lung volumes (TLC); spirometry alone can be misleading.
- Interpreting a modestly reduced raw DLCO as proof of parenchymal disease. In extrinsic restriction DLCO can fall simply because alveolar volume is low—correct for VA and check KCO, which stays normal or high in extrinsic disease but is reduced in intrinsic ILD.
- Treating all ILD the same—management differs dramatically by specific diagnosis (antifibrotics for IPF, where immunosuppression is harmful; immunosuppression for CTD-ILD; antigen avoidance for HP), so an abnormal HRCT is only the start of the workup.
- Overlooking positional hypoxemia in morbidly obese patients—desaturation when supine with clear lungs points to a mechanical/ventilatory (extrinsic) cause rather than parenchymal disease.
- Mislabeling skin findings: erythema nodosum is a clue to sarcoidosis (and to IBD, streptococcal infection, or drug reactions), not a connective tissue disease sign like sclerodactyly or a heliotrope rash.
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.